Avacta Group plc, the developer of Affimer ® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global ...
IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the ...
CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the Zika ...
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "ELISA Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The ...
PathShodh Healthcare, a start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has received the license to manufacture the test for sale of its ...
Enzyme-linked immunosorbent assays (ELISAs) represent the gold standard for quantitatively detecting protein biomarkers, and are used for applications such as diagnosing or monitoring disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results